We suspect that the NLK-mediated increase in AR transactivation results from an increase in cofactor binding at the AR AF-2 domain, thereby supporting a model in which AF-2-mediated interactions are important for SBMA pathogenesis. The gene discussed is NLK; the disease is atrial fibrillation.